Effect of Probiotic Supplement on Bowel Function
- Conditions
- Irritable Bowel Syndrome
- Registration Number
- NCT01475929
- Lead Sponsor
- Danisco
- Brief Summary
The purpose of this study is to analyse the effect of probiotic supplement on symptoms of irritable bowel syndrome.
- Detailed Description
The aim of the intervention is to analyse the effect of a probiotic supplement in a dose-responsive set up on symptoms of irritable bowel syndrome (IBS). Fulfillment of Rome III criteria will be used as inclusion criterion. Subjective assessment of bowel symptoms, IBS-related quality of life and adequate relief will be assessed as outcome measures.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 149
- Subjects aged 18 to 65 with functional bowel symptoms and fulfilling Rome III criteria for IBS will be recruited. Sufficient general health and orientation for participating in the study is required and will be evaluated by the MDs.
- Diagnosed or suspected organic gastrointestinal diseases or severely impaired general health are exclusion criteria.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in functional bowel symptoms 0 weeks, 6 weeks, 12 weeks Validated questionnaire
- Secondary Outcome Measures
Name Time Method Adequate relief Weekly over 3 month intervention Weekly question
Change in faecal microbiota 0 weeks, 6 weeks, 12 weeks Quantification of selected microbes and the intervention strain from faecal samples
Change in quality of life 0 weeks, 6 weeks, 12 weeks Validated questionnaire
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Herttoniemi Hospital
🇫🇮Helsinki, Finland
Herttoniemi Hospital🇫🇮Helsinki, Finland